Cardiff Oncology, Inc. Quarterly Operating Income (Loss) in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cardiff Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q2 2024.
  • Cardiff Oncology, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$12.5M, a 2.76% decline year-over-year.
  • Cardiff Oncology, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$44.6M, a 4.66% decline year-over-year.
  • Cardiff Oncology, Inc. annual Operating Income (Loss) for 2023 was -$45.4M, a 13.8% decline from 2022.
  • Cardiff Oncology, Inc. annual Operating Income (Loss) for 2022 was -$39.9M, a 38.3% decline from 2021.
  • Cardiff Oncology, Inc. annual Operating Income (Loss) for 2021 was -$28.9M, a 51.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$44.6M -$12.5M -$337K -2.76% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$44.3M -$10.9M +$1.12M +9.29% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$45.4M -$10.3M -$940K -10% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$44.5M -$10.8M -$1.83M -20.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$42.6M -$12.2M -$1.77M -16.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$40.9M -$12.1M -$978K -8.83% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$39.9M -$9.39M +$134K +1.41% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$40M -$8.99M -$2M -28.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$38M -$10.4M -$3.55M -51.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$34.5M -$11.1M -$5.63M -103% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$28.9M -$9.53M -$3.03M -46.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$25.8M -$7M -$2.64M -60.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$23.2M -$6.89M -$2.79M -67.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$20.4M -$5.44M -$1.32M -32% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$19.1M -$6.5M -$2.21M -51.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$16.9M -$4.36M -$156K -3.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$16.7M -$4.1M +$118K +2.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$16.8M -$4.12M -$162K -4.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$16.7M -$4.29M -$186K -4.53% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$16.5M -$4.21M -$352K -9.14% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$16.1M -$4.22M +$220K +4.95% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$16.4M -$3.96M +$693K +14.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$17.1M -$4.1M -$319K -8.44% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$16.7M -$3.86M +$1.94M +33.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$18.7M -$4.44M +$1.45M +24.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$20.1M -$4.66M +$5.47M +54% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$25.6M -$3.78M +$6M +61.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$31.6M -$5.8M +$4.13M +41.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$35.7M -$5.89M +$4.09M +41% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$39.8M -$10.1M +$333K +3.18% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$40.1M -$9.78M -$2.4M -32.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-26
Q3 2016 -$37.7M -$9.92M -$3.51M -54.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$34.2M -$9.98M -$3.35M -50.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$30.9M -$10.5M -$5.61M -116% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$25.3M -$7.38M -$2.88M -64% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$22.4M -$6.41M -$2.47M -62.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$19.9M -$6.63M -$3.39M -105% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$16.5M -$4.85M -$1.59M -48.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$14.9M -$4.5M -$1.65M -58.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$13.3M -$3.94M -$863K -28% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$12.4M -$3.24M -$867K -36.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$11.6M -$3.26M -$870K -36.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$10.7M -$2.85M -$1.41M -98.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 -$9.28M -$3.08M -$2.04M -196% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$7.24M -$2.37M -$1.13M -90.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$6.11M -$2.39M -$1.26M -111% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$4.85M -$1.43M -$557K -63.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$4.29M -$1.04M -$307K -41.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$3.99M -$1.25M -$598K -92.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$3.39M -$1.13M -$410K -57% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$2.98M -$877K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 -$732K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$647K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$720K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.